Press Coverage

FDA Worried Drug Was Risky; Now Reports of Death Spark Concern

CNN investigative report explores possible medication safety issues with Nuplazid, a drug approved to treat Parkinson's Disease psychosis, including findings from an ISMP QuarterWatch report analyzing adverse event data. For the full text of the article, visit CNN online.

More News